# US 2025/0180567 A1 · Method for measuring glycosylated surface antigen protein of hbv

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0180567 A1
- Document ID: US20250180567A1
- Status: Published application
- Kind: A1
- Application number: 18/720,960
- Filed: 2021-12-21
- Published: 2025-06-05
- Earliest claimed: 2021-12-21
- Assignees: RCMG Inc.
- Applicants: RCMG Inc.
- Inventors: Hisashi NARIMATSU; Kiyohiko ANGATA; Hiroyuki YONEYAMA
- Web page: https://patentgrep.com/patent/US20250180567A1

## CPC

- G01N 33/5761: {Hepatitis B}
- G01N 33/5764: {Hepatitis B surface antigen}
- G01N 2333/02: Hepadnaviridae, e.g. hepatitis B virus
- G01N 2333/42: Lectins, e.g. concanavalin, phytohaemagglutinin
- G01N 2400/02: involving antibodies to sugar part of glycoproteins
- G01N 2440/38: addition of carbohydrates, e.g. glycosylation, glycation
- G01N 2469/10: Detection of antigens from microorganism in sample from host
- G01N 2470/04: Sandwich assay format
- G01N 2500/00: Screening for compounds of potential therapeutic value
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for detecting hepatitis B virus comprising a step of bringing a sample into contact with an antibody which binds to a surface antigen protein of hepatitis B virus, and a lectin. The surface antigen protein of hepatitis B virus may be an S protein, and the lectin may be wheat germ agglutinin. The detection method may involve an ELISA measurement and may be used for testing, prophylaxis, or planning treatment of hepatitis B virus, and for screening medicines.

## Claims

### Claim 1

A method for detecting hepatitis B virus, comprising:
bringing a sample into contact with an antibody which binds to a surface antigen protein of hepatitis B virus, and a lectin.

### Claim 2 (depends on 1)

The method of claim 1, wherein the surface antigen protein of hepatitis B virus is an S protein.

### Claim 3 (depends on 1)

The method of claim 1, wherein the lectin is wheat germ agglutinin.

### Claim 4 (depends on 1)

The method of claim 1, further comprising:
measuring by an ELISA method.

### Claim 5 (depends on 1)

The method of claim 1, which is for testing, prophylaxis, or planning treatment of hepatitis B virus.

### Claim 6 (depends on 1)

The method of claim 1, for screening medicines for testing, prophylaxis, or treatment of hepatitis B virus.

### Claim 7 (depends on 1)

The method of claim 1, further comprising:
calculating a glycosylated surface antigen protein/surface antigen protein.

### Claim 8 (depends on 1)

The method of claim 1, wherein the sample is derived from a patient who is receiving or has received nucleic acid analog therapy.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sample is derived from a patient whose HBV-DNA suppression in blood has been confirmed.

### Claim 10

A kit for detecting a glycosylated surface antigen protein of hepatitis B virus, the kit comprising:
an antibody that binds to the glycosylated surface antigen protein of hepatitis B virus, and a lectin.

### Claim 11 (depends on 1)

A method for treating or preventing hepatitis B, which includes the method of claim 1.
